Eli Lilly | LLY - Market Capitalization

Stock Price
883.96
Daily Change
-33.69 -3.67%
Monthly
-3.53%
Yearly
-0.07%
Q2 Forecast
865.04

Eli Lilly reported $835.21B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Abbott USD 168.02B 10.39B Apr/2026
ALKERMES USD 4.62B 333M Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Coherus Biosciences USD 172M 19M Dec/2025
Drreddys Laboratories INR 11.69B 50M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 166.62B 14.34B Apr/2026
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
J&J USD 561.65B 17.5B Apr/2026
Merck USD 261.26B 51.62B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Novo Nordisk A/S DKK 1.45T 86.62B Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.97B 105M Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 101.43B 1.16B Apr/2026
Sanofi EUR 117.34B 2.45B Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025